Heinz Wattie’s Ltd, a subsidiary of US branded food giant HJ Heinz Co, has signed a non-exclusive licence agreement with Martek Biosciences Corporation (MBC) on its technology relating to the use of long-chain polyunsaturated fatty acids in infant formula. 

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more


The agreement provides for initial cash payments and would give Martek an ongoing royalty upon Heinz’s introduction of products using Martek’s technology for docosahexaenoic acid (DHA) and arachidonic acid (ARA).


“Martek is pleased to have Heinz as a partner in supplying better nutrition to infants,” said Henry Linsert Jr, chairman and CEO of MBC.

Just Food Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Just Food Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now